The Zepbound Shortage: Resolved for Whom?

The FDA recently announced the end of the shortage for Eli Lilly's anti-obesity medication, Zepbound. This may seem like good news but it’s important to ask: the shortage has been resolved for whom, exactly? Eli Lilly and the FDA may have determined that current Zepbound supplies are sufficient to meet demand, but fail to acknowledge the other type of shortage created by price and insurance inaccessibility. For thousands of patients, they are simply priced out of the system.